PMHNP Practice Authority in Florida: Independence, Physician Agreements and Schedule II

AANP's May 2026 map classes Florida as restricted.

The legal fact behind the label: an APRN performs the functions § 464.012 authorizes within the framework of an established protocol maintained on site, and a practitioner licensed under chapter 458, 459 or 466 maintains supervision for directing the specific course of medical treatment.

There is one exit — registration under s.

464.0123 lifts the protocol requirement — but the same statute confines that registration to primary care practice.

So for a PMHNP weighing Florida, the first question is not how long the protocol lasts but whether the autonomous route covers psychiatric practice at all; the statute and the board rule read do not answer it.

Autonomous registration takes at least 3,000 clinical practice hours within the 5 years immediately preceding the registration request, practised as an APRN under the supervision of an allopathic or osteopathic physician.

Hours are not the whole test: the applicant also needs an active, unencumbered licence under s.

464.012, no disciplinary action in the preceding 5 years, 3 graduate-level semester hours each in differential diagnosis and pharmacology within the past 5 years, and financial responsibility by liability coverage ($100,000 per claim, $300,000 minimum annual aggregate) or an unexpired, irrevocable letter of credit on the same amounts.

The financial-responsibility requirement does not apply to certain registrants, including an APRN practising exclusively for the Federal Government or the state or its agencies or subdivisions, or only alongside teaching duties at an accredited school or its main teaching hospitals.

The registration unlocks practice without the on-site protocol, but only in primary care practice — the statute names family medicine, general pediatrics and general internal medicine, as defined by board rule; whether a PMHNP's specialty psychiatric practice qualifies is not answered by the texts read.

The protocol must be maintained on site at each location where the APRN practises.

Where a group has multiple supervising physicians, the APRN enters a supervisory protocol with at least one physician within the physician group practice, and the physician keeps supervision for directing the specific course of medical treatment.

The sources read set no cap on how many APRNs one physician may supervise.

The caps that are on the books limit offices, and they reach only a medical office other than the physician's primary practice location where the APRN is not under the onsite supervision of a supervising physician: a physician providing primary health care — services commonly provided to patients without referral from another practitioner — may not supervise more than four offices beyond the primary location, and a physician providing specialty health care — services commonly provided to patients with a referral from another practitioner — may not supervise more than two.

Neither definition names psychiatric practice, and the sources read do not classify a psychiatric office under either cap.

Controlled-substance prescribing attaches only to APRNs who graduated from a program leading to a master's or doctoral degree in a clinical nursing specialty area with training in specialized practitioner skills.

The formulary does two things: only APRNs meeting the § 394.455 psychiatric-nurse definition may prescribe psychiatric mental health controlled substances to children under 18, and Schedule II is limited to a 7-day supply except for psychiatric medications prescribed by such a psychiatric nurse.

It has three parts: a master's or doctoral degree in psychiatric nursing, a national advanced practice certification as a psychiatric mental health advanced practice nurse, and 1 year of post-master's clinical experience under a physician's supervision.

An outpatient PMHNP who meets all three can prescribe Schedule II ADHD stimulants without the cap; a PMHNP who does not meet all three is capped at 7 days and cannot prescribe psychiatric controlled substances to children younger than 18.

A psychiatric nurse may also prescribe psychotropic controlled substances for mental disorders within a protocol with a psychiatrist.

A separate Florida controlled-substance registration was not located in the sources read.

A PMHNP registers with the DEA as a mid-level practitioner, and that registration covers only what Florida lets the APRN prescribe.

The DEA form's Schedules II–V line does not suspend the 7-day formulary cap or the psychiatric-nurse conditions.

Telehealth is the same: the DEA and HHS telemedicine flexibilities, extended through December 31, 2026, let registered practitioners prescribe controlled medications remotely without an in-person evaluation, but they lift no state limit — a stimulant prescription written over video still has to fit the formulary rules above.

Florida has not enacted the APRN Compact.

The compact takes effect only once seven states enact it, and as of September 2026 five had (Delaware, North Dakota, South Dakota, Utah and Wyoming), so no APRN holds a multistate APRN licence today.

The Nurse Licensure Compact is an RN compact and gives no nurse practitioner authority in another state.

To practise as a PMHNP in Florida you need a Florida APRN licence — and, unless registered as autonomous under s.

464.0123, a protocol with a supervising physician.

The statute histories record two 2024 edits: s.

50, ch. 2024-245 touched § 464.012, and s.

42, ch. 2024-15 touched § 464.0123.

The text quoted here is the 2026 Florida Statutes and already includes both edits; the research did not isolate what either one changed.

Among the rules read, the formulary rule 64B9-4.016 has stood since its July 30, 2019 amendment, and the primary-care-practice definition in r.

64B9-4.001 was last amended effective February 25, 2021 — that definition is the one that reads behavioral and mental health conditions into primary care practice.

The old protocol-standards rule 64B9-4.010 was repealed effective September 14, 2017.